Prices delayed by at least 15 minutes | Print


Stryker Corp (SYK)

Common Stock
Sell: $299.2|Buy: $349.19|Change: 2.25 (0.69%)

Open 

$327.71


Previous close 

$325.43


Trade high 

$329.43


Volume 

1,688,622


Year high 

$361.41


Year low 

$249.98


Dividend yield 

0.95%


Market capitalisation 

$124.67 bn


P/E ratio 

39.45


ISIN 

US8636671013


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date29/12/202329/03/2024
Ex-dividend date28/12/202327/03/2024
Payment date31/01/202430/04/2024
Amount$0.8$0.8

Performance 22/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Stryker Corp+ 0.69
More...

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.